Page last updated: 2024-10-24

verapamil and Friedreich Disease

verapamil has been researched along with Friedreich Disease in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrés-Sánchez, P1
Subirana-Domènech, M1
Torner-Soler, M1
Casazza, F1
Ferrari, F1
Finocchiaro, G1
Hartwig, J1
Piccone, U1
Tramarin, R1
Morpurgo, M1

Other Studies

2 other studies available for verapamil and Friedreich Disease

ArticleYear
Chest pain during exercise as first manifestation of Friedreich's ataxia.
    British heart journal, 1995, Volume: 74, Issue:4

    Topics: Adolescent; Chest Pain; Disease Progression; Echocardiography; Electrocardiography; Exercise; Friedr

1995
Echocardiographic evaluation of verapamil in Friedreich's ataxia.
    British heart journal, 1986, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Child; Echocardiography; Female; Friedreich Ataxia; Humans; Male; Myocardium; Ver

1986